Bio4241 - Final exam questions, 2015
Wednesday, 15 April, 2-4P
Instructions:
I will select five of the following questions.
Answer any three: you may not answer the
question pertaining to your own group's presentation. Your
answers for each must fit on the front and back of one
lined sheet of paper.
Group 1 – Explain the
genetic phenomena that produce the patterns in the picture of pair-rule gene expression in Drosophila. What
is the technical basis for the different cell
colors?
Group 2 – Compare and
contrast the experimental strategies by which HuGO and the Venter group
obtained the complete sequence of the human genome.
Group 3 - Explain the one-
&
two-step models of cancer induction, using Retinoblastoma as a model.
Group 7 –Explain the
difference between somatic and germline therapies. It
is often suggested that somatic therapy for genetic
diseases is less ethically controversial than germline therapy:
discuss the arguments for and against each as a therapeutic
procedure.
Group 5 - Explain the
concept of the "Mitochondrial Eve" in terms of Most Recent Common
Ancestor and Coalescence.
Group 6 – Explain the construction
of Genetically Modified Organisms (GMOs), e.g.
Monsanto's RoundUp
Ready maize. What are the advantages and
disadvantages, to business and society, of granting patent
protection to GMOs?
SMC: Explain the difference
between the concept of Heritability
and the probability of inheritance. Under what conditions is
heritable variation within
a group likely to be less heritable in one environment than
another? Under what conditions is the difference in
variation between two groups likely to be highly heritable
in one environment, and much less so in another?
KH: Explain the concept of "Duty to Warn".
A physician's primary ethical obligation generally extends
only to the immediate patient, and requires maintenance of
confidentially about the patient's health information. In
exceptional circumstances, ethical duties extend to other
members of society, e.g., mandatory reporting of infectious
disease to a public health officer. Should a physician have
a "duty to
warn" about genetic risks identified in an individual
to members of the patient's extended family? If so, would
such a duty apply to all inherited conditions, or would it
depend upon the actual genetic risk and the nature of the
disease?
All text material ©2015 by Steven M. Carr